| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 7.017 | 7.505 | 2.896 | 62.538 | - | - |
| Total Income - EUR | 27 | 3 | 0 | 0 | 7.017 | 8.449 | 22.249 | 62.946 | - | - |
| Total Expenses - EUR | 513 | 3.148 | 4.897 | 1.760 | 6.688 | 7.796 | 35.198 | 97.752 | - | - |
| Gross Profit/Loss - EUR | -487 | -3.145 | -4.897 | -1.760 | 329 | 653 | -12.950 | -34.806 | - | - |
| Net Profit/Loss - EUR | -487 | -3.145 | -4.897 | -1.760 | 119 | 428 | -13.616 | -36.294 | - | - |
| Employees | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | - | - |
Check the financial reports for the company - Asklepios Medtech S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.800 | 1.781 | 1.751 | 1.719 | 1.686 | 31.989 | 12.023 | 9.450 | - | - |
| Current Assets | 30.038 | 27.646 | 21.515 | 19.360 | 19.138 | 26.557 | 77.731 | 121.845 | - | - |
| Inventories | 670 | 1.344 | 1.321 | 657 | 644 | 632 | 50.040 | 77.030 | - | - |
| Receivables | 12.579 | 11.771 | 12.709 | 11.410 | 11.189 | 19.206 | 20.589 | 26.554 | - | - |
| Cash | 11.907 | 9.699 | 2.734 | 2.630 | 2.732 | 2.234 | 2.715 | 13.860 | - | - |
| Shareholders Funds | 22.245 | 18.873 | 13.656 | 11.646 | 11.539 | 11.748 | -2.128 | -38.429 | - | - |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | - | - |
| Debts | 9.594 | 10.554 | 9.609 | 9.433 | 9.285 | 45.678 | 90.786 | 168.641 | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 1.120 | 1.095 | 1.099 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Asklepios Medtech S.r.l.